Zeitschrift fur GastroenterologieHumansCholangitisSclerosingInflammatory Bowel DiseasesEvidence-Based Medicine
[Immunopathogenesis and therapy of primary sclerosing cholangitis].
Britta F Zecher, Christoph Schramm
Published: 202610.1055/a-2730-4719
Abstract
Primary sclerosing cholangitis (PSC) is an immune-mediated disease of the biliary tract for which no prognosis-improving therapies are yet available. PSC is characterized by genetic risk factors, alterations in the microbiome and pathological immune…
Preview only. Read the full abstract at the source